{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:20:43Z","timestamp":1775341243041,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.14310\/horm.2002.1502","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T13:03:02Z","timestamp":1402923782000},"page":"561-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diabetes mellitus in a girl with thyroid hormone resistance syndrome: a little recognized interaction between the two diseases"],"prefix":"10.1007","volume":"13","author":[{"given":"Stefano","family":"Stagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Manoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Cirello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danila","family":"Covelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Seminara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"de Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"13040561_CR1","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1210\/endo.140.12.7203","volume":"140","author":"M Gurnell","year":"1999","unstructured":"Gurnell M, Rajanayagam O, Agostini M, et al, 1999 Three novel mutations at serine 314 in the thyroid hormone beta receptor differentially impair ligand binding in the syndrome of resistance to thyroid hormone. Endocrinology 140: 5901\u20135906.","journal-title":"Endocrinology"},{"key":"13040561_CR2","first-page":"1109","volume-title":"Werner and Ingbar\u2019s the thyroid: a fundamental and clinical text","author":"S Refetoff","year":"2005","unstructured":"Refetoff S, 2005 Resistance to thyroid hormone. In: Braverman LE, Utiger RE (eds), Werner and Ingbar\u2019s the thyroid: a fundamental and clinical text. Philadelphia: Lippincott, Williams and Wilkins; pp, 1109\u20131129."},{"key":"13040561_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/mend.11.1.9867","volume":"11","author":"JD Safer","year":"1997","unstructured":"Safer JD, Langlois MF, Cohen R, et al, 1997 Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Mol Endocrinol 11: 16\u201326.","journal-title":"Mol Endocrinol"},{"key":"13040561_CR4","first-page":"49","volume":"74","author":"K Takeda","year":"1992","unstructured":"Takeda K, Sakurai A, DeGroot LJ, Refetoff S, 1992 Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor-beta gene. J Clin Endocrinol Metab 74: 49\u201355.","journal-title":"J Clin Endocrinol Metab"},{"key":"13040561_CR5","first-page":"348","volume":"14","author":"S Refetoff","year":"1993","unstructured":"Refetoff S, Weiss RE, Usala SJ, 1993 The syndromes of resistance to thyroid hormone. Endocr Rev 14: 348\u2013399.","journal-title":"Endocr Rev"},{"key":"13040561_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1210\/jcem-27-2-279","volume":"27","author":"S Refetoff","year":"1967","unstructured":"Refetoff S, DeWind LT, DeGroot LJ, 1967 Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 27: 279\u2013294.","journal-title":"J Clin Endocrinol Metab"},{"key":"13040561_CR7","first-page":"272","volume":"51","author":"IA Kourides","year":"1980","unstructured":"Kourides IA, Pekonen F, Weintraub BD, 1980 Absence of thyroid-binding immunoglobulins in patients with thyrotropin-mediated hyperthyroidism. J Clin Endocrinol Metab 51: 272\u2013274.","journal-title":"J Clin Endocrinol Metab"},{"key":"13040561_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF03344156","volume":"29","author":"E Cacciari","year":"2006","unstructured":"Cacciari E, Milani S, Balsamo A, et al, 2006 Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29: 581\u2013593.","journal-title":"J Endocrinol Invest"},{"key":"13040561_CR9","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1210\/jcem-67-5-1089","volume":"67","author":"P Hamon","year":"1988","unstructured":"Hamon P, Bovier-Lapierre M, Robert M, Peynaud D, Pugeat M, Orgiazzi J, 1988 Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: efficacy of D-thyroxine therapy. J Clin Endocrinol Metab 67: 1089\u20131093.","journal-title":"J Clin Endocrinol Metab"},{"key":"13040561_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/thy.1994.4.225","volume":"4","author":"P Beck-Peccoz","year":"1994","unstructured":"Beck-Peccoz P, Chatterjee VK, 1994 The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4: 225\u2013232.","journal-title":"Thyroid"},{"key":"13040561_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1172\/JCI38793","volume":"120","author":"CS Mitchell","year":"2010","unstructured":"Mitchell CS, Savage DB, Dufour S, et al, 2010 Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. J Clin Invest 120: 1345\u20131354.","journal-title":"J Clin Invest"},{"key":"13040561_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1055\/s-2003-40463","volume":"111","author":"A Zinke","year":"2003","unstructured":"Zinke A, Schmoll D, Zachmann M, et al, 2003 Expression of thyroid hormone receptor isoform alpha1 in pancreatic islets. Exp Clin Endocrinol Diabetes 111: 198\u2013202.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"13040561_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1677\/jme.1.02166","volume":"38","author":"C Verga Falzacappa","year":"2007","unstructured":"Verga Falzacappa C, Petrucci E, Patriarca V, et al, 2007 Thyroid hormone receptor TRbeta1 mediates Akt activation by T3 in pancreatic beta cells. J Mol Endocrinol 38: 221\u2013233.","journal-title":"J Mol Endocrinol"},{"key":"13040561_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3181\/00379727-211-43951","volume":"211","author":"P Kopp","year":"1996","unstructured":"Kopp P, Kitajima K, Jameson JL, 1996 Syndrome of resistance to thyroid hormone: insights into thyroid hormone action. Proc Soc Exp Biol Med 211: 49\u201361.","journal-title":"Proc Soc Exp Biol Med"},{"key":"13040561_CR15","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/me.2002-0080","volume":"16","author":"XY Zhang","year":"2002","unstructured":"Zhang XY, Kaneshige M, Kamiya Y, Kaneshige K, McPhie P, Cheng SY, 2002 Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant Beta receptor. Mol Endocrinol 16: 2077\u20132092.","journal-title":"Mol Endocrinol"},{"key":"13040561_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00592-009-0112-9","volume":"46","author":"E Resmini","year":"2009","unstructured":"Resmini E, Minuto F, Colao A, Ferone D, 2009 Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol 46: 85\u201395.","journal-title":"Acta Diabetol"},{"key":"13040561_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0024-3205(02)01791-5","volume":"71","author":"M Fukuchi","year":"2002","unstructured":"Fukuchi M, Shimabukuro M, Shimajiri Y, et al, 2002 Evidence for a deficient pancreatic beta-cell response in a rat model of hyperthyroidism. Life Sci 71: 1059\u20131070.","journal-title":"Life Sci"},{"key":"13040561_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/thy.2007.0249","volume":"18","author":"S Crunkhorn","year":"2008","unstructured":"Crunkhorn S, Patti ME, 2008 Links between thyroid hormone action, oxidative metabolism, and diabetes risk? Thyroid 18: 227\u2013237.","journal-title":"Thyroid"},{"key":"13040561_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1365-2362.2007.01773.x","volume":"37","author":"R Stark","year":"2007","unstructured":"Stark R, Roden M, 2007 ESCI Award 2006. Mitochondrial function and endocrine diseases. Eur J Clin Invest 37: 236\u2013248.","journal-title":"Eur J Clin Invest"},{"key":"13040561_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1399-5448.2008.00347.x","volume":"9","author":"N Abdullah","year":"2008","unstructured":"Abdullah N, Al-Khalidi O, Brown KJ, Reid J, Cheetham TD, 2008 Prolonged honeymoon phase in an adolescent with diabetes and thyrotoxicosis provides support for the accelerator hypothesis. Pediatr Diabetes 9: 417\u2013419.","journal-title":"Pediatr Diabetes"},{"key":"13040561_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.1996.636458.x","volume":"44","author":"K Bech","year":"1996","unstructured":"Bech K, Damsbo P, Eldrup E, et al, 1996 beta-cell function and glucose and lipid oxidation in Graves\u2019 disease. Clin Endocrinol (Oxf) 44: 59\u201366.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"13040561_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2265.1989.tb00435.x","volume":"30","author":"SF Beer","year":"1989","unstructured":"Beer SF, Parr JH, Temple RC, Hales CN, 1989 The effect of thyroid disease on proinsulin and C-peptide levels. Clin Endocrinol (Oxf) 30: 379\u2013383.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"13040561_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2169\/internalmedicine.34.339","volume":"34","author":"S Ohguni","year":"1995","unstructured":"Ohguni S, Notsu K, Kato Y, 1995 Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves\u2019 disease. Intern Med 34: 339\u2013341.","journal-title":"Intern Med"},{"key":"13040561_CR24","first-page":"2033","volume":"80","author":"T Takeda","year":"1995","unstructured":"Takeda T, Suzuki S, Liu RT, DeGroot LJ, 1995 Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 80: 2033\u20132040.","journal-title":"J Clin Endocrinol Metab"},{"key":"13040561_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbalip.2004.01.007","volume":"1682","author":"G Medina-Gomez","year":"2004","unstructured":"Medina-Gomez G, Calvo RM, Obreg\u00f3n MJ, 2004 T3 and Triac inhibit leptin secretion and expression in brown and white rat adipocytes. Biochim Biophys Acta 1682: 38\u201347.","journal-title":"Biochim Biophys Acta"},{"key":"13040561_CR26","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nrd3757","volume":"11","author":"R Coppari","year":"2012","unstructured":"Coppari R, Bj\u00f8rb\u00e6k C, 2012 Leptin revisited: its mechanism of action and potential for treating diabetes. Nat Rev Drug Discov 11: 692\u2013708.","journal-title":"Nat Rev Drug Discov"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.14310\/horm.2002.1502\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.14310\/horm.2002.1502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T15:37:57Z","timestamp":1739115477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.14310\/horm.2002.1502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["13040561"],"URL":"https:\/\/doi.org\/10.14310\/horm.2002.1502","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"29 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}